Factor Xa inhibitors by classical and combinatorial chemistry
- 1 May 1998
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 3 (5), 223-231
- https://doi.org/10.1016/s1359-6446(97)01165-3
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Potential advantages of direct-acting thrombin inhibitorsCoronary Artery Disease, 1996
- Chapter 6. Thrombin and Factor Xa InhibitionPublished by Elsevier ,1996
- Novel Antithrombotic Drugs in DevelopmentDrugs, 1995
- Chapter 8. Anticoagulant Strategies Targeting Thrombin and Factor XaPublished by Elsevier ,1995
- Safety observations from the pilot phase of the randomized r-Hirudin for Improvement of Thrombolysis (HIT-III) study. A study of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK)Circulation, 1994
- Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators.Circulation, 1994
- Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial.Circulation, 1994
- Direct thrombin inhibitors in cardiovascular medicine.Circulation, 1994
- Cell Mediated Events that Control Blood Coagulation and Vascular InjuryAnnual Review of Cell Biology, 1993
- The coagulation cascade: initiation, maintenance, and regulationBiochemistry, 1991